Amporin Pharmaceuticals
Basel
About Amporin Pharmaceuticals
Amporin Pharmaceuticals seeks to create a new class of small-molecule medications that block and eradicate harmful soluble oligomers and holes found within cell membranes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $170.3K
- Last round: Grant (Jul 2024)
- Website: amporin.com
Industries & Categories
Biotechnology, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/amporin-pharmaceuticals-144255 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.